Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
伊沙妥昔单抗、来那度胺、硼替佐米和地塞米松诱导治疗适合移植的新诊断多发性骨髓瘤:GMMG-HD7试验第一部分最终分析
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-02266
Mai, Elias K; Bertsch, Uta; Pozek, Ema; Fenk, Roland; Besemer, Britta; Hanoun, Christine; Schroers, Roland; von Metzler, Ivana; Hänel, Mathias; Mann, Christoph; Leypoldt, Lisa B; Heilmeier, Bernhard; Huhn, Stefanie; Vogel, Sabine K; Hundemer, Michael; Scheid, Christof; Blau, Igor W; Luntz, Steffen; Weinhold, Niels; Tichy, Diana; Holderried, Tobias A W; Trautmann-Grill, Karolin; Gezer, Deniz; Klaiber-Hakimi, Maika; Müller, Martin; Shumilov, Evgenii; Knauf, Wolfgang; Michel, Christian S; Geer, Thomas; Riesenberg, Hendrik; Lutz, Christoph; Raab, Marc S; Benner, Axel; Hoffmann, Martin; Weisel, Katja C; Salwender, Hans J; Goldschmidt, Hartmut